Sanofi Multiple Sclerosis Drug Gets EU Approval

13 hours ago 1
The authorization of Cenrifki for the attraction of secondary progressive aggregate sclerosis without relapses follows a rejection from U.S. cause regulators.
Read Entire Article
  1. Homepage
  2. Health
  3. Sanofi Multiple Sclerosis Drug Gets EU Approval

Related

Is vaginal microbiome testing worth it?

Is vaginal microbiome testing worth it?

2 hours ago 0
American businesses are racing—and taking risks—to get in on the peptide craze.

American businesses are racing—and taking risks—to get in on...

2 hours ago 0
How a heat dome is formed and why experts blame one for Europe's baking temperatures

How a heat dome is formed and why experts blame one for Euro...

3 hours ago 0

Popular

The Hugo Spritz Is the New King of Breezy Summer Drinking

The Hugo Spritz Is the New King of Breezy Summer Drinking

6 days ago 11
Why Waymo’s Driverless Taxis Won’t Be on Your Streets Anytime Soon

Why Waymo’s Driverless Taxis Won’t Be on Your Streets Anytim...

6 days ago 9
Hidden figures: Stephan Gladieu on photographing the people of North Korea

Hidden figures: Stephan Gladieu on photographing the people ...

5 days ago 9
African and Commonwealth nations in Kenya urge quick execution of a key treaty protecting oceans

African and Commonwealth nations in Kenya urge quick executi...

6 days ago 8
Everett Wess wins Democratic nomination for U.S. Senate in Alabama

Everett Wess wins Democratic nomination for U.S. Senate in A...

6 days ago 8
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved